verapamil has been researched along with Symptom Cluster in 30 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the impact of injection of verapamil and adenosine in the coronary arteries on TIMI (Thrombolysis in Myocardial Infarction) frame count (TFC) after percutaneous coronary intervention (PCI) in patients with an acute coronary syndrome (ACS)." | 9.12 | Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. ( de Belder, MA; Graham, J; Hall, JA; Kunadian, B; Sutton, A; Vijayalakshmi, K; Whittaker, VJ; Wright, RA, 2006) |
| "While verapamil has been proposed as a treatment for reducing electrophysiological remodeling due to atrial fibrillation and atrial tachyarrhythmias, no previous study has tested its effects in brady-tachy patients implanted with a dual-chamber pacemaker." | 9.11 | A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker. ( Bertaglia, E; Biffi, M; Boriani, G; Branzi, A; Carboni, A; Latini, R; Martignani, C; Sciotto, F, 2005) |
| "The effect of daily verapamil administration (5 mg/kg) on pain sensitivity, bioelectric activity of cerebral cortex and microcirculation was studied in rats with cut sciatic nerve." | 7.68 | [Effects of verapamil on the development of pain syndrome in rats after section of the sciatic nerve]. ( Gorizontova, MP; Kryzhanovskiĭ, GN; Kukushkin, ML; Reshetniak, VK; Smirnova, VS, 1992) |
| "In the experiments on Wistar rats with pain syndrome of spinal origin (PSSO) caused by the generator of pathologically enhanced excitation (GPEE) in dorsal horns of the spinal cord lumbosacral segments, it was shown that the intravenous verapamil injection (1." | 7.68 | [Effects of verapamil on behavioral and microcirculatory disorders in pain syndrome of spinal etiology]. ( Gorizontova, MP; Igon'kina, SI; Kryzhanovskiĭ, GI; Speranskaia, TV, 1990) |
| "To study the impact of injection of verapamil and adenosine in the coronary arteries on TIMI (Thrombolysis in Myocardial Infarction) frame count (TFC) after percutaneous coronary intervention (PCI) in patients with an acute coronary syndrome (ACS)." | 5.12 | Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. ( de Belder, MA; Graham, J; Hall, JA; Kunadian, B; Sutton, A; Vijayalakshmi, K; Whittaker, VJ; Wright, RA, 2006) |
| "While verapamil has been proposed as a treatment for reducing electrophysiological remodeling due to atrial fibrillation and atrial tachyarrhythmias, no previous study has tested its effects in brady-tachy patients implanted with a dual-chamber pacemaker." | 5.11 | A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker. ( Bertaglia, E; Biffi, M; Boriani, G; Branzi, A; Carboni, A; Latini, R; Martignani, C; Sciotto, F, 2005) |
| "Using PubMed and Google Scholar, we performed a search of the English language literature with several combinations of the keywords "intra-arterial", "calcium channel blockers", "reversible cerebral vasoconstriction syndrome", "RCVS", "nimodipine", "verapamil", "milrinone", and "nicardipine" to identify studies in which RCVS was treated with IA calcium channel blockers." | 3.88 | Chemical angioplasty for medically refractory reversible cerebral vasoconstriction syndrome ( Al-Mufti, F; Alchaki, A; Dodson, V; El-Ghanem, M; Gupta, G; Hidalgo, A; Nuoman, R; Roychowdhury, S; Sutherland, A; Thabet, A; Wajswol, E, 2018) |
| " The headache syndrome and angiographic findings resolved after starting low-dose verapamil." | 3.76 | Exertional reversible cerebral vasoconstriction responsive to verapamil. ( Krasnokutsky, MV; Scott, BR; Theeler, BJ, 2010) |
| "We report a case of fulminating systemic capillary leak syndrome which temporarily responded to verapamil, a calcium channel blocker." | 3.69 | Fulminating systemic capillary leak syndrome with lymphocytosis and hypogammaglobulinemia. ( Hays, RM; Kang, PM; Khan, GA; Lawrence, C, 1995) |
| "The effect of daily verapamil administration (5 mg/kg) on pain sensitivity, bioelectric activity of cerebral cortex and microcirculation was studied in rats with cut sciatic nerve." | 3.68 | [Effects of verapamil on the development of pain syndrome in rats after section of the sciatic nerve]. ( Gorizontova, MP; Kryzhanovskiĭ, GN; Kukushkin, ML; Reshetniak, VK; Smirnova, VS, 1992) |
| "In the experiments on Wistar rats with pain syndrome of spinal origin (PSSO) caused by the generator of pathologically enhanced excitation (GPEE) in dorsal horns of the spinal cord lumbosacral segments, it was shown that the intravenous verapamil injection (1." | 3.68 | [Effects of verapamil on behavioral and microcirculatory disorders in pain syndrome of spinal etiology]. ( Gorizontova, MP; Igon'kina, SI; Kryzhanovskiĭ, GI; Speranskaia, TV, 1990) |
| "Cardiogenic shock is associated with primary myocardial failure and a low-flow state." | 2.36 | Calcium entry blockers: potential applications in shock. ( Greenfield, LJ; Hess, ML, 1983) |
| "Verapamil was administered i." | 1.25 | [Venous infusion of nerapamil in the treatment of refractory angina pectoris and arrhythmia due to associated electric instability]. ( Furlanello, F; Lanzetta, T; Pascotto, P; Piccolo, E; Trevi, GP, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (33.33) | 18.7374 |
| 1990's | 6 (20.00) | 18.2507 |
| 2000's | 10 (33.33) | 29.6817 |
| 2010's | 4 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pace, J | 1 |
| Nelson, J | 1 |
| Ray, A | 1 |
| Hu, Y | 1 |
| Al-Mufti, F | 1 |
| Dodson, V | 1 |
| Wajswol, E | 1 |
| El-Ghanem, M | 1 |
| Alchaki, A | 1 |
| Nuoman, R | 1 |
| Thabet, A | 1 |
| Sutherland, A | 1 |
| Roychowdhury, S | 1 |
| Hidalgo, A | 1 |
| Gupta, G | 1 |
| Koncz, I | 1 |
| Gurabi, Z | 1 |
| Patocskai, B | 1 |
| Panama, BK | 1 |
| Szél, T | 1 |
| Hu, D | 1 |
| Barajas-Martínez, H | 1 |
| Antzelevitch, C | 1 |
| Bouchard, M | 1 |
| Verreault, S | 1 |
| Gariépy, JL | 1 |
| Dupré, N | 1 |
| Theeler, BJ | 1 |
| Krasnokutsky, MV | 1 |
| Scott, BR | 1 |
| Skelding, KA | 1 |
| Goldstein, JA | 1 |
| Mehta, L | 1 |
| Pica, MC | 1 |
| O'Neill, WW | 1 |
| Bailey, PM | 1 |
| Little, M | 1 |
| Jelinek, GA | 1 |
| Wilce, JA | 1 |
| Boes, CJ | 1 |
| Matharu, MS | 1 |
| Goadsby, PJ | 1 |
| Pasquetto, G | 1 |
| Reimers, B | 1 |
| Favero, L | 1 |
| Saccà, S | 1 |
| Cernetti, C | 1 |
| Napodano, M | 1 |
| Piccolo, P | 1 |
| Pascotto, P | 2 |
| Kannankeril, PJ | 1 |
| Roden, DM | 1 |
| Fish, FA | 1 |
| Boriani, G | 1 |
| Bertaglia, E | 1 |
| Carboni, A | 1 |
| Latini, R | 1 |
| Biffi, M | 1 |
| Martignani, C | 1 |
| Sciotto, F | 1 |
| Branzi, A | 1 |
| Vijayalakshmi, K | 1 |
| Whittaker, VJ | 1 |
| Kunadian, B | 1 |
| Graham, J | 1 |
| Wright, RA | 1 |
| Hall, JA | 1 |
| Sutton, A | 1 |
| de Belder, MA | 1 |
| Tanabe, Y | 1 |
| Hatada, K | 1 |
| Naito, N | 1 |
| Aizawa, Y | 4 |
| Chinushi, M | 2 |
| Nawa, H | 1 |
| Tagawa, M | 1 |
| Nakamura, Y | 1 |
| Hess, ML | 1 |
| Greenfield, LJ | 1 |
| Ward, DE | 1 |
| Camm, J | 1 |
| Myles, PS | 1 |
| Olenikov, I | 1 |
| Bujor, MA | 1 |
| Davis, BB | 1 |
| Kang, PM | 1 |
| Lawrence, C | 1 |
| Khan, GA | 1 |
| Hays, RM | 1 |
| Miyazaki, T | 1 |
| Mitamura, H | 1 |
| Miyoshi, S | 1 |
| Soejima, K | 1 |
| Ogawa, S | 1 |
| Monzillo, PH | 1 |
| Sanvito, WL | 1 |
| Peres, MF | 1 |
| Puletti, M | 1 |
| Curione, M | 1 |
| Piccolo, E | 1 |
| Furlanello, F | 1 |
| Trevi, GP | 1 |
| Lanzetta, T | 1 |
| Kryzhanovskiĭ, GN | 1 |
| Reshetniak, VK | 1 |
| Kukushkin, ML | 1 |
| Gorizontova, MP | 2 |
| Smirnova, VS | 1 |
| Kryzhanovskiĭ, GI | 1 |
| Igon'kina, SI | 1 |
| Speranskaia, TV | 1 |
| Golikov, AP | 1 |
| Rudnev, DV | 1 |
| Lang, B | 1 |
| Newsom-Davis, J | 1 |
| Wray, DW | 1 |
| Romeo, F | 1 |
| Gaspardone, A | 1 |
| Ciavolella, M | 1 |
| Gioffrè, P | 1 |
| Reale, A | 1 |
| Winniford, MD | 1 |
| Willerson, JT | 1 |
| Hillis, LD | 1 |
| Vohra, J | 1 |
| Peter, T | 1 |
| Hunt, D | 1 |
| Sloman, G | 1 |
| Fujii, J | 1 |
| Takahashi, N | 1 |
| Kato, K | 1 |
3 reviews available for verapamil and Symptom Cluster
| Article | Year |
|---|---|
Jellyfish envenoming syndromes: unknown toxic mechanisms and unproven therapies.
Topics: Animals; Antihypertensive Agents; Antivenins; Australia; Bites and Stings; Cnidarian Venoms; Cubozoa | 2003 |
Calcium entry blockers: potential applications in shock.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Disease; Diltiazem; Dogs | 1983 |
Calcium antagonists for acute ischemic heart disease.
Topics: Acute Disease; Angina Pectoris, Variant; Angina, Unstable; Calcium Channel Blockers; Coronary Diseas | 1985 |
3 trials available for verapamil and Symptom Cluster
| Article | Year |
|---|---|
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiac Pacing, A | 2005 |
Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes.
Topics: Adenosine; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Circulatio | 2006 |
Verapamil versus acebutolol for syndrome X.
Topics: Acebutolol; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Mi | 1988 |
24 other studies available for verapamil and Symptom Cluster
| Article | Year |
|---|---|
Verapamil-induced breakdown of the blood-brain barrier presenting as a transient right middle cerebral artery syndrome.
Topics: Blood-Brain Barrier; Carotid Artery, Internal; Cerebral Angiography; Computed Tomography Angiography | 2017 |
Chemical angioplasty for medically refractory reversible cerebral vasoconstriction syndrome
Topics: Angioplasty; Calcium Channel Blockers; Drug Resistance; Female; Humans; Infusions, Intra-Arterial; M | 2018 |
Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac | 2014 |
Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome.
Topics: Anti-Inflammatory Agents; Brain; Calcium Channel Blockers; Cerebral Angiography; Female; Headache Di | 2009 |
Exertional reversible cerebral vasoconstriction responsive to verapamil.
Topics: Adult; Calcium Channel Blockers; Cerebrovascular Circulation; Humans; Magnetic Resonance Angiography | 2010 |
Resolution of refractory no-reflow with intracoronary epinephrine.
Topics: Abciximab; Acute Disease; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Bl | 2002 |
The paroxysmal hemicrania-tic syndrome.
Topics: Aged; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fructose; | 2003 |
Distal filter protection during percutaneous coronary intervention in native coronary arteries and saphenous vein grafts in patients with acute coronary syndromes.
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Balloon Occlusion; Biomarkers; Blood Vessel Pro | 2003 |
Suppression of bidirectional ventricular tachycardia and unmasking of prolonged QT interval with verapamil in Andersen's syndrome.
Topics: Adolescent; Anti-Arrhythmia Agents; Diagnosis, Differential; Electrocardiography; Female; Glycogen S | 2004 |
Over-expression of Kv1.5 in rat cardiomyocytes extremely shortens the duration of the action potential and causes rapid excitation.
Topics: Action Potentials; Adenoviridae; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cells, Cultu | 2006 |
Shortening of the ventricular fibrillatory intervals after administration of verapamil in a patient with Brugada syndrome and vasospastic angina.
Topics: Adult; Angina Pectoris; Anti-Arrhythmia Agents; Bundle-Branch Block; Coronary Vasospasm; Electrocard | 2006 |
Mechanisms of junctional tachycardias in the Lown-Ganong-Levine syndrome.
Topics: Adolescent; Adult; Atrioventricular Node; Cardiac Pacing, Artificial; Electrocardiography; Electroph | 1983 |
ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Cardiopulmonary Bypas | 1993 |
Fulminating systemic capillary leak syndrome with lymphocytosis and hypogammaglobulinemia.
Topics: Agammaglobulinemia; Calcium Channel Blockers; Capillary Permeability; Humans; Lymphocytosis; Male; M | 1995 |
Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Disopyramide; Electrocardiography; Humans; | 1996 |
[Cluster-tic syndrome: two case reports].
Topics: Adult; Carbamazepine; Cluster Headache; Humans; Male; Prednisone; Syndrome; Trigeminal Neuralgia; Ve | 1996 |
[Drug therapy of pre-excitation syndromes].
Topics: Adrenergic beta-Antagonists; Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrilla | 1977 |
[Venous infusion of nerapamil in the treatment of refractory angina pectoris and arrhythmia due to associated electric instability].
Topics: Adult; Angina Pectoris; Angiography; Arrhythmias, Cardiac; Atrial Fibrillation; Coronary Angiography | 1975 |
[Effects of verapamil on the development of pain syndrome in rats after section of the sciatic nerve].
Topics: Animals; Evoked Potentials; Male; Microcirculation; Pain; Rats; Rats, Wistar; Sciatic Nerve; Somatos | 1992 |
[Effects of verapamil on behavioral and microcirculatory disorders in pain syndrome of spinal etiology].
Topics: Animals; Behavior, Animal; Dipyrone; Male; Microcirculation; Pain; Rats; Rats, Inbred Strains; Spina | 1990 |
[Reperfusion syndrome during thrombolytic therapy of myocardial infarct].
Topics: Arrhythmias, Cardiac; Female; Fibrinolytic Agents; Hemodynamics; Humans; Male; Mexiletine; Middle Ag | 1989 |
The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle.
Topics: 4-Aminopyridine; Action Potentials; Aminopyridines; Animals; Calcium Channels; Heart; Heart Ventricl | 1988 |
Verapamil induced premature ventricular beats before reversion of supraventricular tachycardia.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Bradycardia; Digoxin; Electrocardiogr | 1974 |
The bradycardia-tachycardia syndrome. Treatment with cardiac drugs and adrenal corticosteroid.
Topics: Adolescent; Aged; Atropa belladonna; Bradycardia; Electrocardiography; Female; Heart Block; Heart Co | 1973 |